Vantage Investment Partners’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.9M Buy
100,995
+1,703
+2% +$211K 0.82% 39
2025
Q4
$12.5M Buy
99,292
+22,189
+29% +$2.89M 0.83% 40
2025
Q3
$11.3M Hold
77,103
0.77% 42
2025
Q2
$12M Buy
77,103
+593
+0.8% +$94K 0.88% 42
2025
Q1
$12.6M Buy
+76,510
New +$12.7M 1.06% 38
2020
Q4
Sell
-1,328
Closed -$220K 84
2020
Q3
$220K Buy
+1,328
New +$204K 0.01% 79
2020
Q2
Sell
-71,662
Closed -$8.43M 85
2020
Q1
$8.43M Buy
71,662
+8,080
+13% +$1.06M 0.73% 25
2019
Q4
$8.41M Buy
63,582
+60
+0.1% +$7.46K 0.69% 47
2019
Q3
$7.91M Sell
63,522
-23,263
-27% -$2.81M 0.82% 45
2019
Q2
$9.85M Buy
86,785
+58
+0.1% +$6.07K 1.13% 23
2019
Q1
$8.73M Buy
+86,727
New +$7.87M 0.81% 41

Other funds holding ZTS

Vantage Investment Partners's ZTS Position: Q1 2026 in Review

Vantage Investment Partners increased its Zoetis (ZTS) stake by 1.7% in Q1 2026, buying an estimated $211K and bringing the position to 100,995 shares worth $11.9M. The position accounts for 0.82% of the portfolio, ranked #39.

Vantage Investment Partners first reported a position in ZTS in Q1 2019 and has held it in 11 quarters since. The position peaked at $12.6M in Q1 2025. 1,604 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • Vantage Investment Partners held 100,995 shares of Zoetis worth $11.9M as of Q1 2026.
  • Vantage Investment Partners bought 1,703 Zoetis shares in Q1 2026, an estimated $211K.
  • Zoetis made up 0.82% of Vantage Investment Partners's portfolio in Q1 2026, its #39 holding.
  • Vantage Investment Partners first reported a position in Zoetis in Q1 2019 and has held it in 11 quarters since.
  • Vantage Investment Partners's Zoetis position peaked at $12.6M in Q1 2025.
  • 1,604 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on Vantage Investment Partners's 13F filing for Q1 2026, filed 1 May 2026.